Sorriso Pharmaceuticals

Sorriso is a biopharmaceutical company advancing a pipeline of disease-modifying antibodies for the treatment of immune-mediated diseases, including Crohn’s disease and ulcerative colitis. The company's platform generates potent antibodies that can be delivered orally and are designed to maintain activity throughout the human intestine.

Sorriso Pharmaceuticals

Sandy, UT San Diego, CA

Website